Nanotech Investing Soleno Therapeutics to Present at the Piper Sandler 37th Annual Healthcare Conference
Nanotech Investing Satellos Announces Publication in Nature Communications Supporting its Novel Treatment Approach for Duchenne Muscular Dystrophy
Nanotech Investing Anixa Biosciences Announces World Health Organization Approval of International Non-Proprietary Name for its CAR-T Therapy, Marking a Key Milestone Toward Global Recognition and Future Commercialization
Nanotech Investing Silo Pharma Partners with Allucent to Support Planned FDA Investigational New Drug Application for SPC-15 as a Therapeutic for PTSD
Nanotech Investing Qualigen Therapeutics Stockholders Approve All Proposals with Majority Vote; Company to Rebrand as AIxCrypto Holdings, Inc. Following November 20 Nasdaq Ceremony and Announces Transition into AI × Web3 Strategy
Nanotech Investing Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates
Nanotech Investing Satellos Reports Third Quarter 2025 Results and Announces Appointment of Mark Nawacki to Board of Directors
Nanotech Investing Anixa Biosciences Awarded Key U.S. Patent Expanding Breast Cancer Vaccine IP Protection into 2040s
Nanotech Investing Soleno Therapeutics Announces Entry Into $100 Million Accelerated Share Repurchase Agreement
Nanotech Investing Anixa Biosciences to Participate in Water Tower Research Fireside Chat on Tuesday, November 11, 2025
Nanotech Investing Anixa Biosciences Announces Execution of Data Transfer Agreement with Cleveland Clinic
Nanotech Investing Vaxcyte Reports Third Quarter 2025 Financial Results and Provides Business Update Including Final Data from Positive VAX-24 Infant Phase 2 Dose-Finding Study
Nanotech Investing Longeveron® Announces Third Quarter 2025 Financial Results and Provides Business Update
Homerun Resources Inc. Announces Listing of Its Shares on Tradegate Exchange in Germany Increasing European and International Market Liquidity
